Results 131 to 140 of about 3,487 (207)

Is it MOGAD or pediatric MS?

open access: yesArquivos de Neuro-Psiquiatria
Stella Duarte Pinto   +8 more
openaire   +1 more source

Use of Fluid Biomarkers in NMOSD and MOGAD: Clinical and Research Applications. [PDF]

open access: yesNeurol Neuroimmunol Neuroinflamm
Mariotto S   +15 more
europepmc   +1 more source

Interleukin 6 Receptor Blockade for Relapse Prevention in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease. [PDF]

open access: yesJAMA Neurol
Vilaseca A   +57 more
europepmc   +1 more source

Lökodistrofi Benzeri Patern Ile Başvuran MOGAD Olgusu (PP-082) "A Case of MOGAD Presenting with Leukodystrophy-Like Pattern (PP-082)"

open access: yes
Amaç:Miyelinoligodendrositglikoprotein(MOG)antikoruileilişkilihastalık(MOGAD)santralsinirsisteminin(SSS)otoimmündemiyelinizanhastalığıdır.Çocuklardatümakutdemiyelinizansendromlarınyaklaşıküçtebirinioluşturmaktadır.
Arhan, Ebru   +8 more
core  

MOGAD-Like Encephalitic Syndromes Without MOG Antibodies in Children. [PDF]

open access: yesNeurol Neuroimmunol Neuroinflamm
Olivé-Cirera G   +22 more
europepmc   +1 more source

MYELIN OLIGODENDROCYTE ANTIBODY ASSOCIATED DISEASE (MOGAD): A REVIEW OF MECHANISMS, CLINICAL FEATURES, PATHOLOGY, AND NEW DEVELOPMENTS

open access: yes
Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease (MOGAD) was defined as a neuroimmune disorder of the central nervous system in 2007. In recent years, clinicians and researchers have been working to identify the mechanisms behind the
Abraham, Freya
core  

Home - About - Disclaimer - Privacy